Technology

ORCL.N
IBM.N
HPQ.N

BRIEF-Trig Social Media Q6 net sales EUR 60,313, down from Q5

* Q6 net sales 60,313 euros ($67,750) versus 232,051 euros in Q5

8:02am EST

EU agency recommends approval of Otsuka kidney drug

LONDON, Feb 27 - A new kidney disease drug from Japan's Otsuka has been recommended for approval in Europe, the region's medicines regulator said on Friday.

Healthcare 7:18am EST

BRIEF-EU agency backs Sanofi diabetes drug Toujeo plus medicines from Otsuka, Novartispproval in advanced non small cell lung cancer

Feb 27 - European Medicines Agency: * EU medicines agency says recommends approval of new Sanofi diabetes

China draft counterterror law strikes fear in foreign tech firms

BEIJING/WASHINGTON, Feb 27 - China is weighing a far-reaching counterterrorism law that would require technology firms to hand over encryption keys and install security "backdoors", a potential escalation of what some firms view as the increasingly onerous terms of doing business in the world's second largest economy.

7:02am EST

BRIEF-Exelis Q4 earnings from continuing operations $0.45/share

* Q4 earnings per share from continuing operations ex-items $0.47

Stocks, Markets, Earnings 6:42am EST

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Brown Brothers Harriman & Co.
$23.00
Provider: Brown Brothers Harriman & Co.
$12.00
Provider: Brown Brothers Harriman & Co.
$35.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.